Compare Davita Inc (DVA) vs Royal Bank of Canada (RY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Royal Bank of Canada — how do they compare? Davita Inc trades at $232.01 (market cap $15.12B), while Royal Bank of Canada trades at $215.06 (market cap $291.56B). The key difference: Royal Bank of Canada is far larger — about 19.3× Davita Inc's market cap, and Royal Bank of Canada pays a 2.42% dividend while Davita Inc pays none. Which is the better fit depends on your goals.
| DVA | RY | |
|---|---|---|
Market Cap | $15.12B | $291.56B |
Sector | Health | Financials |
52-Week High | $235.71 | $214.04 |
52-Week Low | $103.87 | $128.46 |
Enterprise Value | $27.67B | — |
Dividend Yield | — | 2.42% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Royal Bank of Canada
Royal Bank of Canada is one of the two largest banks in Canada. It is a diversified financial services company, offering personal and commercial banking, wealth-management services, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada, with additional operations in the U.S. and other countries.
Read more on RY →
